Search

PHAVES #13 will be a seminar with Prof. Jonathan Iredell, MBBS, PhD of the Westmead Institute for Medical Research and University of Sydney on Wed, March 10 at 8AM AEDT (Tues, March 9 at 4PM Eastern Time/10PM CET). He will give a talk entit

The Texas Medical Center (TMC) Digestive Diseases Center 12th Frontiers in Digestive Diseases Symposium “Phages, Viruses, and Digestive Diseases” will take place Saturday, March 6, 2021, 8 am CST – 1:45 pm CST. Event Organizers: Mary K. Est

Thanks to all who attended 2021 Phage Futures Congress last week! The conference conducted a Young Researchers Poster Competition, and announced the four finalists on the last day. Congratulations to: - Carmen Gu Liu (Baylor College of Med

We are in search for Pseudomonas aeruginosa phage PaP3, it was described by Fuquan Hu’s lab but myself and Prof. Gino Cingolani haven’t received a reply from them. Hope you can help us find this prophage or a similar one to this and LUZ24 (

BCM TAILΦR Labs (Tailored Antibacterials and Innovative Laboratories for phage (Φ) Research) and a team of their collaborators was awarded a 7.5 million dollar U19 grant by the National Institute of Allergy and Infectious Diseases. Congrats

Martin Jahn and colleagues recently published an interesting paper on the lifestyle of phages of marine sponges by host prediction and correlative microscopy. They used a new correlative in situ imaging approach (‘PhageFISH-CLEM‘) to locali

Luis Camarillo-Guerrero (Wellcome Sanger Insititute) and colleagues published a paper on the prevalence of viral diversity in the human gut, along with a new Gut Phage Database (142,809 non-redundant gut phage genomes from 28,060 metagenome

Few have explored how phages affect bacteria associated with winemaking. Cécile Philippe (University of Bordeaux, France) and colleagues published a new paper in Frontiers in Microbiology on the characterization of the first virulent phages

Varun Rakeshbhai Bavda (IISER, India) and colleagues published a new article on the molecular properties of mycobacteriophage D29 Holin, with an emphasis on potential for holin engineering. They demonstrated crucial amino acid regions for h

PHAVES #13 will be a seminar with Prof. Jonathan Iredell, MBBS, PhD of the Westmead Institute for Medical Research and University of Sydney on Wed, March 10 at 8AM AEDT (Tues, March 9 at 4PM Eastern Time/10PM CET). He will give a talk entit

Good things…. come to those who wait. It is now evident that corona will continue to disrupt our plans to share science and meet at VoM Portugal yet again this year. The local organizers of the upcoming VoM conferences and the ISVM board ha

We are excited to announce that the Viruses of Microbes 2024 meeting will be held in Cairns, Australia! Being situated on the shores of the Great Barrier Reef and surrounded by the oldest rainforest on Earth, Cairns will host a truly unique

The International Bacteriophage Research Consortium (IBRC) and Phage Directory are co-hosting a series of Phage Bioinformatics Webinars. The second speaker in the series will be March 2 at 9.00 pm IST / 7.30 am PST, with a talk by Katelyn

phageSuisse is hosting its second webinar on March 2nd at 20h00 CET on "Temperate bacteriophages and the evolution of the Staphylococcus aureus lineage 398" by Dr. Floriane Laumay from Geneva, Switzerland. Register here!

The NIH Wednesday Afternoon Lecture Series (WALS) is hosting Prof. Paul Turner on Wednesday, March 10 - 3:00pm to 4:00pm, who will give a webinar entitled "Phage Therapy to Combat Infections by Antibiotic-Resistant Bacteria". Watch at https

The Centre for Microbiology and Phage Therapy (Zewail City of Science, Technology and Innovation) is organizing their first Annual Phage International Conference on March 12-13, 2021. Register here (conference already in progress!).

Locus Biosciences announced the completion of a phase 1b trial of CRISPR-Cas3-enhanced phage targeting E. coli in urinary tract infections. The trial met all the endpoints, and represents the first randomized, placebo-controlled trial using

TechnoPhage has initiated a phase I/IIa study to test a phage treatment for diabetic foot infections. This product is the first of TechnoPhage’s pipeline to enter clinical trials, constituting an exciting milestone for the company. The resu

Esther Shmidov (Bar-Ilan University, Israel) and colleagues published a new paper on a counter selection-based novel method of curing prophages in Pseudomonas aeruginosa. They validated their method with local PCR amplification and whole-ge

Shayla Hesse (National Cancer Institute, USA) and colleagues published a new paper showing that mutations in genes coding for cell surface structures impair adsorption of phages in multidrug-resistant Klebsiella pneumoniae. They concluded t